headline
"ABBV-951 in Parkinson's Disease Forecasts and Impacts to 2032: Investigational Status and Clinical Advancements, Market Forecast and Clinical Assessment, Impact on Treatment Scenario - ResearchAndMarkets.com"
PGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Here's Why
Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
What's Behind The 2x Jump In AbbVie Stock?
What the Options Market Tells Us About AbbVie - AbbVie (NYSE:ABBV)
Spotlight on AbbVie: Analyzing the Surge in Options Activity - AbbVie (NYSE:ABBV)
Is AbbVie Inc. (ABBV) the Best Cancer Stock to Buy Now?
Behind the Scenes of AbbVie's Latest Options Trends - AbbVie (NYSE:ABBV)
$ABBV | ($ABBV) Pivots Trading Plans and Risk Controls (ABBV)
Bristol Myers Squibb Vs. AbbVie Stock
Behind the Scenes of AbbVie's Latest Options Trends - AbbVie (NYSE:ABBV)
Spotlight on AbbVie: Analyzing the Surge in Options Activity - AbbVie (NYSE:ABBV)
"AbbVie Stock Up Almost 20% in 3 Months: Buy, Sell or Hold?"
RHHBY or ABBV: Which Is the Better Value Stock Right Now?
Pfizer Stock Vs. AbbVie
Czech National Bank Boosts Stake in AbbVie Inc. (NYSE:ABBV)
"AbbVie Inc. (NYSE:ABBV) Receives Consensus Rating of ""Moderate Buy"" from Analysts"
AbbVie (NYSE:ABBV) Releases FY24 Earnings Guidance
"Brown Financial Advisors Purchases Shares of 4,222 AbbVie Inc. (NYSE:ABBV)"
AbbVie (NYSE:ABBV) Trading Up 0.4%
"MBB Public Markets I LLC Purchases 120,819 Shares of AbbVie Inc. (NYSE:ABBV)"
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
AbbVie (NYSE:ABBV) Stock Price Up 0.5%
AbbVie (NYSE:ABBV) Stock Price Down 0.2%
AbbVie (NYSE:ABBV) Trading Down 0.7%  - Should You Sell?
Neville Rodie & Shaw Inc. Increases Stock Holdings in AbbVie Inc. (NYSE:ABBV)
AbbVie (NYSE:ABBV)  Shares Down 0.3%
AbbVie Inc. (NYSE:ABBV) Short Interest Down 8.7% in September
AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V
AbbVie Inc. (NYSE:ABBV) Shares Bought by Magnolia Capital Advisors LLC
Annandale Capital LLC Has $4.99 Million Stock Position in AbbVie Inc. (NYSE:ABBV)
"Alethea Capital Management LLC Makes New $488,000 Investment in AbbVie Inc. (NYSE:ABBV)"
15 Unhealthiest Countries in Latin America
AbbVie (NYSE:ABBV) Stock Price Up 1.5%
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years - AbbVie (NYSE:ABBV)
AbbVie (NYSE:ABBV) Trading 0.1% Higher
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
AbbVie Inc. (NYSE:ABBV) Shares Sold by Fred Alger Management LLC
AbbVie (NYSE:ABBV)  Shares Down 0.7%
AbbVie a Top Ranked SAFE Dividend Stock With 3.2% Yield (ABBV)
"Deutsche Bank reiterates hold rating on AbbVie, steady stock target By Investing.com"
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today - AbbVie (NYSE:ABBV)
"Abbvie stock under pressure from Humira volume decline, says Deutsche Bank By Investing.com"
Deutsche Bank maintains Hold rating on Abbvie stock amid Humira trends By Investing.com
AbbVie (NYSE:ABBV) Stock Price Down 0.4%
AbbVie (NYSE:ABBV) Shares Up 0.5%
ABBV Quantitative Stock Analysis
AbbVie Inc. (NYSE:ABBV) Shares Sold by Truist Financial Corp
Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment
AbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights
AbbVie Inc. (NYSE:ABBV) Shares Sold by Zurich Insurance Group Ltd FI
1832 Asset Management L.P. Has $21.08 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV)
EMA Committee Endorses AbbVie's Elahere in Ovarian Cancer
ABBV Quantitative Stock Analysis
EMA endorses AbbVie's ovarian cancer drug ELAHERE By Investing.com
Abbie Inc.(ABBV) stocks Elliott Wave technical analysis [Video]
AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
Guru Fundamental Report for ABBV
Avoid Nightmares With SCHD (NYSEARCA:SCHD)
AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
ABBV Factor-Based Stock Analysis
"Top Stock Reports for Visa, AbbVie & Anheuser-Busch"
Resistance of estrogen receptor function to BET bromodomain inhibition is mediated by transcriptional coactivator cooperativity - Nature Structural & Molecular Biology
ABBV Quantitative Stock Analysis
"10 Health Care Stocks With Whale Alerts In Today's Session - Cigna (NYSE:CI), AbbVie (NYSE:ABBV)"
ABBV Quantitative Stock Analysis
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
"FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket - BeiGene (NASDAQ:BGNE), AbbVie (NYSE:ABBV)"
"Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal - AbbVie (NYSE:ABBV), UnitedHealth Group (NYSE:UNH)"
3 top pharma stocks to buy in october 2024
Available Nationwide: JUVÃ‰DERM ® VOLUMA ® XC for Moderate to Severe Temple Hollowing By Investing.com
"Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition - Annovis Bio (NYSE:ANVS), AbbVie (NYSE:ABBV)"
NetworkNewsWire: Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition
BMO maintains AbbVie Outperform rating with price target By Investing.com
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease - AbbVie (NYSE:ABBV)
Should You Invest in the Vanguard Health Care ETF (VHT)?
Tavapadon shows promise in Parkinson's disease trial By Investing.com
RINVOQ shows promise in atopic dermatitis head and neck treatment By Investing.com
Empowering Women Entrepreneurs: 2024 BOTOX ® (onabotulinumtoxinA) Cosmetic Grant Recipients Kick Off Crowdfunding Campaigns By Investing.com
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
Bristol-Myers Squibb's KarXT Faces FDA Approval Hurdles: Analyst Issues Sell Rating Amid Labeling Concerns
Abbott's Still Crushing It (NYSE:ABT)
